Malignant Soft Tissue Neoplasm — Trials

Malignant Soft Tissue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,396 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 341
Recruiting: 190
Ph III recruiting: 14
Growth YoY: −18.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (200)

clinicaltrialsPublishedShowing 51–100 of 241 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04887298	Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases	completed	Phase 1 / Phase 2	36	Moleculin Biotech, Inc.INDUSTRY	1	Oct 24, 2024	clinicaltrials
NCT03345485	Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.(EDO-S101)	completed	Phase 1 / Phase 2	71	Mundipharma Research LimitedINDUSTRY	5	Oct 21, 2024